Latest filing published 17 Aug 2026 for ImageneBio, Inc..
Yanina Grant-Huerta is a declared insider at 2 companies; the most frequent names are Atara Biotherapeutics, Inc. and ImageneBio, Inc. In total, 14 filings cover trades dated from 16 May 2025 to 14 August 2026.
No open-market purchase appears, only 11 sales worth €61k. Other entries cover 3 share grants. In 2026 alone, the filings show no purchases and 4 sales.
The newest entry dates from 17 August 2026: a share grant, in ImageneBio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations